said that the scientists knew
that there were some important and beneficial microbes which are present in
lower numbers in people with inflammatory bowel disease. The difference between
healthy individuals and patients were substantial, with patients having a less
stable
. Dr. Jansson is the study's
corresponding author but she was assisted by scientists from Germany, United
States, Sweden and Spain.
‘Probiotic yogurt could improve beneficial microbiome in patients with inflammatory bowel disease.’
Fluctuations in the
Gut Microbiome
Inflammatory
bowel disease belongs to a group of diseases where the immune system of the
patient targets the microbes in the host gut resulting in a
chronic
inflammatory disease. There are two main types of IBD,
Crohn's disease and
ulcerative colitis. The main symptoms of both the
types of inflammatory bowel disease are
- Swelling, cramps
or pain in the stomach
- Bloody diarrhea
- Fatigue
- Weight loss
- Anemia
- Vomiting
- Fever
The
symptoms that are associated with IBD are not consistent; there could be
periods of intense symptoms, termed
flare-ups, and periods where there
are no symptoms, termed
remission.
The
treatment for inflammatory bowel disease involves the administration of
anti-inflammatory
drugs as well as
steroids. In extreme cases,
surgery would
have to be considered.
Difference between Microbiome of Intestinal
Bowel Disease (IBD) Patients and Healthy people:
It
has always been known that the microbiome of people with inflammatory bowel
disease
- had fewer
beneficial microbes
- was more likely to
have E. coli and Enterobacteriaceae
Dr.
Colin Brislawn who was associated with the statistical
analysis and is a PNNL scientist said that the study was designed to identify
not only what microbes were present in patients with inflammatory bowel disease
but how the microbial community changed as the symptoms of the patient became
worse. The study showed that there was a dynamic nature of the disease which
correlated with the dynamic nature of the microbes in the gut.
Studying the Gut
Microbiome
Gastroenterologist,
D. Jonas Halfvarson from the Örebro University and colleagues analyzed
137 people, which included patients with
ulcerative colitis, ileal disease
and Crohn's disease, as well as healthy controls, for a period of two
years.
- Fecal samples
were collected for two years, once every three months
- Symptoms of the
patients were monitored
- Totally, the
study resulted in the collection of 683 fecal samples
- Genetic
sequencing technique was utilized to identify the microbes
The findings of the study were, while the
gut microbial community was stable over time among healthy participants, in
patients with IBD
- Gut microbiome
was inconsistent
- There were
dramatic shifts in microbiomes
- Certain bacteria
were almost absent at some point
- A considerable
population of microbiome was replaced by other microbes in just a few months
- People with Ileal
disease showed maximum discrepancy in microbiome community
- Patients who
consumed steroids were faced with more microbiome fluctuations
- Flare-ups in
symptoms were also associated with microbiome fluctuations
The
study can be used to identify the course of the disease and analyze the
effectiveness of the medications administered using the microbiome of the
intestine.
Dr.
Halfvarson said that the results were an important step in identifying how the
microbiome was associated with the dynamism of the inflammatory bowel disease.
Alterations in the microbiome by mirroring the microbiome of healthy
individuals could aid in better treatment.
The
scientists involved in the study claim that avoiding immune suppressants could
play a key role in preventing flare-ups while the addition of beneficial
microbiome in the intestine of patients with the inflammatory bowel disease
could maintain patients in remission.
It
has always been fascinating to understand the intricacy of the relationship
between gut microbiome and the health of an individual. The current study that
focuses on the relevance of gut microbiome on the symptoms associated with
inflammatory bowel disease highlights the need to actively maintain a
'beneficial'
species of microbiome.
References :- Inflammatory Bowel Diseases - (http://www.nhs.uk/conditions/inflammatory-bowel-disease/pages/introduction.aspx)
Source: Medindia